Exelixis, Inc. ( EXEL ) was a big mover last session, as the company saw its shares rise over 10% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past one month's volatile price range of $2.57 to $3.22.
This biopharmaceutical company has seen 5 positive estimate revisions in the last 60 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if Friday's rally can turn into more strength down the road.
Exelixis currently has a Zacks Rank #2 (Buy).
Investors interested in the Bio-Med/Gene industry may also consider Actelion Ltd. ( ALIOF ) that sports a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.